Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Anthrax Vaccine Market, by Region, 2019-2027 (USD Billion)
1.2.2. Anthrax Vaccine Market, by Vaccine type, 2019-2027 (USD Billion)
1.2.3. Anthrax Vaccine Market, by Application, 2019-2027 (USD Billion)
1.2.4. Anthrax Vaccine Market, by Distribution Channel, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Anthrax Vaccine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Anthrax Vaccine Market Dynamics
3.1. Anthrax Vaccine Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increased consumption of undercooked/raw meat
3.1.1.2. Growing burden of anthrax globally
3.1.2. Market Restraint
3.1.2.1. High cost associated with vaccine
3.1.2.2. Lack of awareness for diagnostic test of target disease
3.1.3. Market Opportunities
3.1.3.1. Technological development
Chapter 4. Global Anthrax Vaccine Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Anthrax Vaccine Market, by Vaccine type
5.1. Market Snapshot
5.2. Global Anthrax Vaccine Market by Vaccine type , Performance - Potential Analysis
5.3. Global Anthrax Vaccine Market Estimates & Forecasts by Vaccine type 2018-2027 (USD Billion)
5.4. Anthrax Vaccine Market , Sub Segment Analysis
5.4.1. Live Attenuated Vaccine
5.4.2. Cell Free PA Vaccine
Chapter 6. Global Anthrax Vaccine Market, by Application
6.1. Market Snapshot
6.2. Global Anthrax Vaccine Market by Application, Performance - Potential Analysis
6.3. Global Anthrax Vaccine Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
6.4. Anthrax Vaccine Market , Sub Segment Analysis
6.4.1. Animal Use
6.4.2. Human Use
Chapter 7. Global Anthrax Vaccine Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Anthrax Vaccine Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Anthrax Vaccine Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)
7.4. Anthrax Vaccine Market , Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Pharmacies
7.4.3. Other Distribution Channels
Chapter 8. Global Anthrax Vaccine Market, Regional Analysis
8.1. Anthrax Vaccine Market , Regional Market Snapshot
8.2. North America Anthrax Vaccine Market
8.2.1. U.S. Anthrax Vaccine Market
8.2.1.1. Vaccine type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Application breakdown estimates & forecasts, 2018-2027
8.2.1.3. Distribution Channel breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Anthrax Vaccine Market
8.3. Europe Anthrax Vaccine Market Snapshot
8.3.1. U.K. Anthrax Vaccine Market
8.3.2. Germany Anthrax Vaccine Market
8.3.3. France Anthrax Vaccine Market
8.3.4. Spain Anthrax Vaccine Market
8.3.5. Italy Anthrax Vaccine Market
8.3.6. Rest of Europe Anthrax Vaccine Market
8.4. Asia-Pacific Anthrax Vaccine Market Snapshot
8.4.1. China Anthrax Vaccine Market
8.4.2. India Anthrax Vaccine Market
8.4.3. Japan Anthrax Vaccine Market
8.4.4. Australia Anthrax Vaccine Market
8.4.5. South Korea Anthrax Vaccine Market
8.4.6. Rest of Asia Pacific Anthrax Vaccine Market
8.5. Latin America Anthrax Vaccine Market Snapshot
8.5.1. Brazil Anthrax Vaccine Market
8.5.2. Mexico Anthrax Vaccine Market
8.6. Rest of The World Anthrax Vaccine Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Colorado Serum Co
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Emergent BioSolutions
9.2.3. Indian Immunologicals Ltd
9.2.4. Porton Biopharma Ltd
9.2.5. Biogenesis Bago
9.2.6. Merck & Co. Inc.
9.2.7. Zoetis Inc.
9.2.8. Bayer AG
9.2.9. Altimmune (PharmAthene Inc.)
9.2.10. Agrovet
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption